Logo image of BBH

VANECK BIOTECH ETF (BBH) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:BBH - US92189F7261 - ETF

196.377 USD
+3.24 (+1.68%)
Last: 11/25/2025, 8:26:21 PM
Fundamental Rating

4

BBH gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 82 industry peers in the Automobile Components industry. Both the profitability and the financial health of BBH get a neutral evaluation. Nothing too spectacular is happening here. BBH is quite expensive at the moment. It does show a decent growth rate. Finally BBH also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

BBH had positive earnings in the past year.
In the past year BBH had a positive cash flow from operations.
In the past 5 years BBH has always been profitable.
In the past 5 years BBH always reported a positive cash flow from operatings.
BBH Yearly Net Income VS EBIT VS OCF VS FCFBBH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

1.2 Ratios

Looking at the Return On Assets, with a value of 4.39%, BBH is in line with its industry, outperforming 45.12% of the companies in the same industry.
With a Return On Equity value of 8.81%, BBH perfoms like the industry average, outperforming 46.34% of the companies in the same industry.
With a Return On Invested Capital value of 8.17%, BBH perfoms like the industry average, outperforming 43.90% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for BBH is in line with the industry average of 8.52%.
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROIC 8.17%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
BBH Yearly ROA, ROE, ROICBBH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a Profit Margin value of 5.84%, BBH perfoms like the industry average, outperforming 48.78% of the companies in the same industry.
BBH's Profit Margin has been stable in the last couple of years.
BBH has a Operating Margin (10.65%) which is in line with its industry peers.
BBH's Operating Margin has been stable in the last couple of years.
BBH has a Gross Margin (27.60%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of BBH has remained more or less at the same level.
Industry RankSector Rank
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
BBH Yearly Profit, Operating, Gross MarginsBBH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BBH is creating some value.
The number of shares outstanding for BBH has been reduced compared to 1 year ago.
BBH has less shares outstanding than it did 5 years ago.
BBH has a worse debt/assets ratio than last year.
BBH Yearly Shares OutstandingBBH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BBH Yearly Total Debt VS Total AssetsBBH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

An Altman-Z score of 5.85 indicates that BBH is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 5.85, BBH belongs to the best of the industry, outperforming 87.80% of the companies in the same industry.
BBH has a debt to FCF ratio of 6.05. This is a slightly negative value and a sign of low solvency as BBH would need 6.05 years to pay back of all of its debts.
BBH's Debt to FCF ratio of 6.05 is on the low side compared to the rest of the industry. BBH is outperformed by 62.20% of its industry peers.
A Debt/Equity ratio of 0.32 indicates that BBH is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.32, BBH is doing worse than 63.41% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Altman-Z 5.85
ROIC/WACC1.04
WACC7.84%
BBH Yearly LT Debt VS Equity VS FCFBBH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

BBH has a Current Ratio of 1.80. This is a normal value and indicates that BBH is financially healthy and should not expect problems in meeting its short term obligations.
BBH's Current ratio of 1.80 is on the low side compared to the rest of the industry. BBH is outperformed by 71.95% of its industry peers.
BBH has a Quick Ratio of 1.12. This is a normal value and indicates that BBH is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of BBH (1.12) is worse than 73.17% of its industry peers.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.12
BBH Yearly Current Assets VS Current LiabilitesBBH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

BBH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.28%.
The Earnings Per Share has been growing slightly by 1.64% on average over the past years.
BBH shows a decrease in Revenue. In the last year, the revenue decreased by -3.62%.
The Revenue has been growing slightly by 2.41% on average over the past years.
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%

3.2 Future

BBH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.26% yearly.
BBH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.85% yearly.
EPS Next Y0.74%
EPS Next 2Y8.86%
EPS Next 3Y11.26%
EPS Next 5YN/A
Revenue Next Year-4.87%
Revenue Next 2Y-1.29%
Revenue Next 3Y0.41%
Revenue Next 5Y2.85%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BBH Yearly Revenue VS EstimatesBBH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
BBH Yearly EPS VS EstimatesBBH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 77.62 indicates a quite expensive valuation of BBH.
Based on the Price/Earnings ratio, BBH is valued a bit more expensive than the industry average as 78.05% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Earnings ratio of 25.98, BBH is valued quite expensively.
A Price/Forward Earnings ratio of 54.79 indicates a quite expensive valuation of BBH.
Based on the Price/Forward Earnings ratio, BBH is valued a bit more expensive than 79.27% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.79. BBH is valued rather expensively when compared to this.
Industry RankSector Rank
PE 77.62
Fwd PE 54.79
BBH Price Earnings VS Forward Price EarningsBBH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BBH indicates a slightly more expensive valuation: BBH is more expensive than 76.83% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, BBH is valued a bit more expensive than 73.17% of the companies in the same industry.
Industry RankSector Rank
P/FCF 96.82
EV/EBITDA 25.17
BBH Per share dataBBH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)104.96
PEG (5Y)47.25
EPS Next 2Y8.86%
EPS Next 3Y11.26%

7

5. Dividend

5.1 Amount

BBH has a Yearly Dividend Yield of 5.10%, which is a nice return.
Compared to an average industry Dividend Yield of 4.49, BBH pays a better dividend. On top of this BBH pays more dividend than 97.56% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, BBH pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.1%

5.2 History

On average, the dividend of BBH grows each year by 7.84%, which is quite nice.
BBH has paid a dividend for at least 10 years, which is a reliable track record.
BBH has decreased its dividend recently.
Dividend Growth(5Y)7.84%
Div Incr Years1
Div Non Decr Years1
BBH Yearly Dividends per shareBBH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8 1

5.3 Sustainability

BBH pays out 62.40% of its income as dividend. This is not a sustainable payout ratio.
The dividend of BBH is growing, but earnings are growing more, so the dividend growth is sustainable.
DP62.4%
EPS Next 2Y8.86%
EPS Next 3Y11.26%
BBH Yearly Income VS Free CF VS DividendBBH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B
BBH Dividend Payout.BBH Dividend Payout, showing the Payout Ratio.BBH Dividend Payout.PayoutRetained Earnings

VANECK BIOTECH ETF

NASDAQ:BBH (11/25/2025, 8:26:21 PM)

196.377

+3.24 (+1.68%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)02-22 2026-02-22/amc
Inst Owners46.28%
Inst Owner Change-13.82%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap138.59B
Revenue(TTM)26.74B
Net Income(TTM)1.56B
Analysts79.17
Price Target213.58 (8.76%)
Short Float %0%
Short Ratio0.57
Dividend
Industry RankSector Rank
Dividend Yield 5.1%
Yearly Dividend1.56
Dividend Growth(5Y)7.84%
DP62.4%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.94%
PT rev (3m)10.54%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-16.83%
EPS NY rev (3m)-17.93%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.93%
Revenue NY rev (3m)-3.29%
Valuation
Industry RankSector Rank
PE 77.62
Fwd PE 54.79
P/S 4.49
P/FCF 96.82
P/OCF 35.49
P/B 6.77
P/tB 9.2
EV/EBITDA 25.17
EPS(TTM)2.53
EY1.29%
EPS(NY)3.58
Fwd EY1.83%
FCF(TTM)2.03
FCFY1.03%
OCF(TTM)5.53
OCFY2.82%
SpS43.74
BVpS28.99
TBVpS21.34
PEG (NY)104.96
PEG (5Y)47.25
Graham Number40.62
Profitability
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROCE 10.41%
ROIC 8.17%
ROICexc 9.37%
ROICexgc 11.66%
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
FCFM 4.64%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
ROICexc(3y)10.45%
ROICexc(5y)9.86%
ROICexgc(3y)12.91%
ROICexgc(5y)12.2%
ROCE(3y)11.87%
ROCE(5y)10.97%
ROICexgc growth 3Y-1.17%
ROICexgc growth 5Y0.57%
ROICexc growth 3Y-1.78%
ROICexc growth 5Y0.45%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Debt/EBITDA 1.17
Cap/Depr 107.96%
Cap/Sales 8.01%
Interest Coverage 9.96
Cash Conversion 70%
Profit Quality 79.44%
Current Ratio 1.8
Quick Ratio 1.12
Altman-Z 5.85
F-Score5
WACC7.84%
ROIC/WACC1.04
Cap/Depr(3y)113.8%
Cap/Depr(5y)101.88%
Cap/Sales(3y)7.8%
Cap/Sales(5y)7.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
EPS Next Y0.74%
EPS Next 2Y8.86%
EPS Next 3Y11.26%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%
Revenue Next Year-4.87%
Revenue Next 2Y-1.29%
Revenue Next 3Y0.41%
Revenue Next 5Y2.85%
EBIT growth 1Y-17.5%
EBIT growth 3Y1.98%
EBIT growth 5Y1.14%
EBIT Next Year59.12%
EBIT Next 3Y22.78%
EBIT Next 5Y17.06%
FCF growth 1Y-20.46%
FCF growth 3Y21.5%
FCF growth 5Y7.22%
OCF growth 1Y-10.1%
OCF growth 3Y14.27%
OCF growth 5Y5.48%

VANECK BIOTECH ETF / BBH FAQ

What does VANECK BIOTECH ETF do?

Compagnie Générale des Établissements Michelin SCA engages in the manufacture, distribution and sale of tires. The company is headquartered in Clermont-Ferrand, Auvergne-Rhone-Alpes and currently employs 127,500 full-time employees. The firm operates through three segments: Automotive, Road Transportation and Specialty Businesses. Automotive, which comprises the business lines Automotive business to customers (B2C) Global Brands, Automotive B2C Regional Brands, Automotive Original Equipment and Mobility Experiences. Road Transportation comprises the business lines Long Distance Transportation, Urban Transportation and Services & Solutions. Specialty Businesses comprises the business lines Mining, Off-Highway Transportation, Two-Wheel, Aircraft and High-Tech Materials. The company provides different kind of tires and related products and services through a dealership network. Its service offering includes truck driver assistance with Michelin Euro Assist, fleet tire advice, maintenance and management services and mobility assistance services, among others. Additionally, it provides branded lifestyle products and high-tech materials.


Can you provide the latest stock price for VANECK BIOTECH ETF?

The current stock price of BBH is 196.377 USD. The price increased by 1.68% in the last trading session.


How is the ChartMill rating for VANECK BIOTECH ETF?

BBH has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Which stock exchange lists BBH stock?

BBH stock is listed on the Nasdaq exchange.